Skip to main content
Clinical Trials/NCT03918694
NCT03918694CompletedNot Applicable

Vitamin C Supplementation for Lumbar Spine Surgical Patients

University of Kansas Medical Center2 sites in 1 country55 target enrollmentStarted: June 30, 2019Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
55
Locations
2
Primary Endpoint
Adherence feasibility outcome

Study Overview

Brief Summary

By doing this study, researchers hope to learn effects of Vit C on lumbar spine surgery outcomes.

Detailed Description

Lumbar spine surgeries are common procedures for management of low back pain and their prevalence is increasing. However, their outcomes are less than optimal.

An effective and inexpensive solution to minimizing surgical complications and expediting recovery following lumbar spine surgery could be supplementation using high doses of vitamin C, also known as ascorbic acid. Vit C can help reduce oxidative stress and inflammation and improve immune system and body's own chemicals to fight pain.

The researchers want to examine if Vit C is effective in decreasing pain and pain medications and improving function. Gaining a better understanding of effects of Vit C on patient recovery may lead to improved outcomes.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Triple (Participant, Care Provider, Outcomes Assessor)

Masking Description

Blinded pilot randomized control trial

Eligibility Criteria

Ages
45 Years to 80 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patients scheduled to have a lumbar spine fusion
  • Can read and understand the English language
  • BMI 35 or less

Exclusion Criteria

  • Patients taking certain medications
  • lumbar spine laminectomy or discectomy
  • taking a Vit C supplement
  • pregnancy
  • Cauda equine syndrome or spinal tumor
  • neurological, neurodegenerative or cognitive issues
  • renal pathology
  • sickle cell anemia
  • iron metabolism disorder

Outcomes

Primary Outcomes

Adherence feasibility outcome

Time Frame: up to 7 weeks

Calculate adherence in percentage as subjects enrolled versus completed

Function

Time Frame: up to 7 weeks

Gait distance in feet will be obtained during physical therapy visit

Would healing

Time Frame: up to 7 weeks

Surgical incision observation

Pain intensity: numeric rating pain scale

Time Frame: up to 7 weeks

self reported 0-10 numeric rating pain scale where 0=no pain and 10=most pain imagined

Pain medication consumption

Time Frame: up to 7 weeks

Use of opioids and non-opioids analgesics documented in patients' health records

Recruitment feasibility outcome

Time Frame: up to 7 weeks

The number of participants recruited and enrolled.

Secondary Outcomes

  • Vit C level(up to 7 weeks)
  • Beck depression inventory(up to 7 weeks)
  • Beck anxiety inventory(up to 7 weeks)
  • 2011 Fibromyalgia (FM) survey(up to 7 weeks)
  • fatigue questionnaire(up to 7 weeks)
  • Pittsburg sleep scale(up to 7 weeks)
  • Pain catastrophizing scale(up to 7 weeks)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials